The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

INDIANAPOLIS, Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025.Lilly will …

Feb 6, 2024 · New Products(i) revenue grew by $2.19 billion to $2.49 billion in Q4 2023, led by Mounjaro and Zepbound. Growth Products(ii) revenue increased 9% to $5.27 billion in Q4 …

20 hours ago · Eli Lilly is up 6.8% during the same time and is heading into earnings with an average analyst price target of $972.57 (compared to the current share price of $840.50).

14 hours ago · Eli Lilly will announce Q4 2024 results, with analysts estimating $13.7 billion in sales and $4.94 EPS, alongside a revenue growth outlook for 2024.

Jan 14, 2025 · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. The …

Jan 13, 2025 · Analysts expect Eli Lilly’s EPS to climb 107.9% to $13.14 in fiscal 2024, up from $6.32 in 2023. In fiscal 2025, EPS is projected to increase by 82.9% annually to $24.03.

Jan 14, 2025 · (RTTNews) - Drug major Eli Lilly and Co. (LLY) on Tuesday trimmed its fourth-quarter revenue view below the Street estimates, but raised forecast for fiscal 2024 revenues. …

23 hours ago · Eli Lilly is set to report Q4 2024 earnings on February 6, 2025, with management expecting $13.5 billion in revenue—a massive 45% year-over-year jump. Driving this surge? …

Jan 14, 2025 · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. The …